TWD 30.0
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 217.28 Million TWD | 15.22% |
2022 | 188.57 Million TWD | -7.83% |
2021 | 204.6 Million TWD | -26.0% |
2020 | 276.47 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 240.31 Million TWD | 10.6% |
2024 Q2 | 260.98 Million TWD | 8.6% |
2023 Q3 | 216.98 Million TWD | 20.76% |
2023 Q2 | 179.67 Million TWD | -7.33% |
2023 FY | 217.28 Million TWD | 15.22% |
2023 Q1 | 193.88 Million TWD | 0.0% |
2023 Q4 | 217.28 Million TWD | 0.14% |
2022 Q4 | - TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 63.875% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | -39.79% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | -415.238% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 80.174% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 86.405% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 80.171% |
Center Laboratories, Inc. | 269.22 Million TWD | 19.295% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | -186.666% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | 7.134% |
InnoPharmax Inc. | 22.24 Million TWD | -876.851% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | -56.535% |
DV Biomed Co., Ltd. | 96.51 Million TWD | -125.127% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | -71.359% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -650.694% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 23.455% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | -87.738% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -2056.849% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | -288.349% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | -83.522% |